Together, these findings indicate that TTFields suppress tumor growth while promoting a selective functional reprogramming of tumor-associated macrophages, characterized by enhanced iNOS expression in both M1-like and a subset of M2-like macrophages, without depleting the M2 population or reducing Arg1 levels in vivo. This evidence concerns the gene ARG1 and neoplasm.